Walter Freiherr von Stein
Direttore Tecnico/Scientifico/R&S presso miacom diagnostics GmbH
Provenienza dei contatti di primo grado di Walter Freiherr von Stein
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
miacom diagnostics GmbH
 miacom diagnostics GmbH BiotechnologyHealth Technology miacom diagnostics GmbH develops and distributes rapid molecular diagnostic tests for the identification of pathogens directly from patient material. Its products include hemoFISH Gram, hemoFISH Masterpanel, hemoFISH S.aureus and CNS Screen, respiFISH HAP Gram Panel, respiFISH HAP Masterpanel, FISH Probes, Combined hotplate and hybridization chamber, 8-channel pipette, and fluorescence microscopes. The company was founded by Ian Thrippleton and Walter Freiherr von Stein in 2009 and is headquartered in Düsseldorf, Germany.
3
| Subsidiary | Biotechnology | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Walter Freiherr von Stein tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Difco Laboratories, Inc.
 Difco Laboratories, Inc. BiotechnologyHealth Technology Part of Thermo Fisher Scientific, Inc., Difco Laboratories, Inc. produces products to help detect bacterial contamination in food and drugs. The company is based in Detroit, MI. The company was founded by Ian P. Thrippleton. Difco Laboratories was acquired by Becton, Dickinson & Co. on July 02, 1997. | Biotechnology | Founder | |
Seapro Diagnostics Ltd.
 Seapro Diagnostics Ltd. Pharmaceuticals: MajorHealth Technology Part of SnowWorld NV, Seapro Diagnostics Ltd. is a British company that manufactures and markets biopharmaceuticals and related products. The company is based in Liverpool, UK. Seapro Diagnostics was acquired by Fornix BioSciences NV on October 29, 2003. | Pharmaceuticals: Major | Chief Operating Officer | |
| Max-Planck-Institute for Molecular Genetics | College/University | Doctorate Degree | |
| Heinrich-Heine-Universität Düsseldorf | College/University | Graduate Degree | |
Ventac Partners GmbH
 Ventac Partners GmbH Miscellaneous Commercial ServicesCommercial Services Ventac Partners GMBH offers life sciences consultancy services. Its consulting services include due diligence, education and training, market analysis, product development and valuation. The company was founded by Mikael Oerum in 2002 and is headquartered in Munich, Germany. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Kenan-Flagler Business School | College/University | Masters Business Admin | |
| The University of North Carolina at Charlotte | College/University | Doctorate Degree | |
Julz Co. Llc
 Julz Co. Llc Investment ManagersFinance Julz Co LLC (Julz) is a venture capital firm founded in 2016. The firm is headquartered in Chapel Hill, North Carolina. | Investment Managers | Private Equity Investor | |
Bluejay Mobile Health, Inc.
 Bluejay Mobile Health, Inc. Internet Software/ServicesTechnology Services Bluejay Mobile Health, Inc. is a full-service medical mobile technology and telehealth company. The company is headquartered in Livermore, CA. | Internet Software/Services | Private Equity Investor | |
Lino Biotech AG
 Lino Biotech AG Miscellaneous Commercial ServicesCommercial Services Lino Biotech AG provides foal molography technology. It is a novel label-free biosensor platform for direct imaging of biomolecular interactions in living cells. The company was founded by Mirko Stange, Volker Gatterdam, and Andreas Fruter and is headquartered in Zurich, Switzerland. | Miscellaneous Commercial Services | Founder | |
Elastrin Therapeutics, Inc.
 Elastrin Therapeutics, Inc. BiotechnologyHealth Technology Elastrin Therapeutics, Inc. is a biotech company based in Simpsonville, SC. Elastrin Therapeutics is developing novel therapies to reverse cardiovascular disease using a proprietary platform that targets and restores degraded elastin by removing harmful calcification that stiffens arteries. The platform significantly improves the efficacy of drugs and eliminates side effects by combining particle design with elastin targeting. The company's treatment, a nanoparticle that specifically targets elastin, is able to reverse calcification in the arteries and other tissues, providing a solution to heart disease, stroke, high blood pressure, COPD, and aneurysm. The company was founded by Mirko Stange, Douglas Mulhall, Naren Vyavahare, Charles D. Rice, Valentin Busch, and Markus Zils. The CEO is Matthias Breugelmans. | Biotechnology | Founder | |
| Bogaziçi University | College/University | Undergraduate Degree | |
| University of North Carolina at Chapel Hill | College/University | Doctorate Degree | |
Qbiotix Ltd.
 Qbiotix Ltd. Information Technology ServicesTechnology Services Qbiotix Ltd. develops medical diagnostic technology. The company is based in Ledbury, UK. | Information Technology Services | Director/Board Member | |
| KXTbio, Inc. | Director/Board Member | ||
| Droege Group Internationale Unternehmer-Beratung GmbH | Corporate Officer/Principal |
Statistiche
Distribuzione geografica
| Stati Uniti | 8 |
| Germania | 6 |
| Regno Unito | 3 |
| Svizzera | 2 |
Settori
| Consumer Services | 7 |
| Health Technology | 4 |
| Commercial Services | 3 |
| Technology Services | 3 |
| Health Services | 2 |
Posizioni
| Founder | 5 |
| Director/Board Member | 4 |
| Doctorate Degree | 3 |
| Private Equity Investor | 3 |
| Corporate Officer/Principal | 2 |
Contatti più connessi
| Insiders | |
|---|---|
| Mirko Stange | 7 |
| Sezgin Ozgur | 7 |
| Ian Thrippleton | 6 |
- Borsa valori
- Insiders
- Walter Freiherr von Stein
- Connessioni Società
